An estimated 50 million people around the world currently live with Alzheimer's disease or other dementias, dementia being a collective term for progressive syndromes that affect various expressions of cognitive function, such as memory and emotional expression. Alzheimer’s disease accounts for the majority of cases (50 to 70%, varying by country, based on Alzheimer’s Disease International and World Health Organization figures).

Edible macroalgae (i.e., ‘seaweeds’) are a nutritious and sustainable alternative to animal-based proteins. However, consumption of seaweeds in Western countries remains low, and little is known about individual drivers of acceptance. The aim of this study was to further explore the consumer acceptability of seaweed-based food products in the UK. In an online study (N = 476), participants were presented with a general description of edible seaweeds, and descriptions of seaweed-based food products (e.g., ‘seaweed burger’).
 Share of direct out-of-pocket, informal care, and direct public and private health and LTC insurance costs of dementia in 2018.
An article on dementia and Alzheimer's disease costs, in the context of SDG 3, focusing specifically on the economic costs of care in Europe.
An Article on readmission to depressive symptoms among people who are refugees, in the context of SDGs 3 and 10, focusing specifically on the effectiveness and cost-effectiveness of care practices for this population in Germany.
This study reinforces understanding that adverse incidents have a profound impact on the mental health and wellbeing of healthcare professionals.
An Article on adolescent depression, in the context of SDG 3, focusing specifically on internet-based psychodynamic therapy.
An Article on long-term psychosocial outcomes associated with combat injuries among military personnel, in the context of SDG 3, focusing specifically on rates of post-traumatic stress disorder, depression, anxiety, and mental health multimorbidity.
An Article on readmission to psychiatric hospital care, in the context of SDG 3, focusing specifically on whether peer support reduces readmissions.

The Lancet Psychiatry, Volume 8, Issue 8, August 2021, Pages 673-685.

An Article on substance use, in the context of SDG 3, focusing specifically on the difference in substance use between autistic and non-autistic people.
This book chapter advances SDG #3 and #10 by focusing on an emblematic delayed-onset pathology often seen after traumatic brain injury—Alzheimer’s disease—and explain its relationship with chronic traumatic encephalopathy.